Elisabetta Chiarparin

10PUBLICATIONS
37CO-AUTHORS
Molecular targetsPharmaceutical delivery technologiesCharacterisation of biological macromoleculesGene and molecular therapyBiomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 31, 2024
Discovery and In Vivo Efficacy of AZ-PRMT5i-1, a Novel PRMT5 Inhibitor with High MTA Cooperativity.

James M Smith, Bernard Barlaam, David Beattie

|Jul 30, 2024
Structural and Physicochemical Features of Oral PROTACs.

Markus Schade, James S Scott, Thomas G Hayhow

|Apr 06, 2022
In-Cell Quantification of Drugs by Magic-Angle Spinning Dynamic Nuclear Polarization NMR.

Andrea Bertarello, Pierrick Berruyer, Markus Artelsmair

|Feb 08, 2022
Discovery of a Potent and Selective ATAD2 Bromodomain Inhibitor with Antiproliferative Activity in Breast Cancer Models.

Jon J Winter-Holt, Catherine Bardelle, Elisabetta Chiarparin

|Apr 26, 2021
Fragment-Based Design of a Potent MAT2a Inhibitor and in Vivo Evaluation in an MTAP Null Xenograft Model.

Claudia De Fusco, Marianne Schimpl, Ulf Börjesson

|Mar 01, 2021
Correction to "Free Ligand 1D NMR Conformational Signatures To Enhance Structure Based Drug Design of a Mcl-1 Inhibitor (AZD5991) and Other Synthetic Macrocycles".

Amber Y S Balazs, Rodrigo J Carbajo, Nichola L Davies

Pageof 2

Frequent Collaborators

6 joint publications

James S Scott

4 joint publications

Graeme Robb

2 joint publications

Jeffrey W Johannes

2 joint publications

Michelle L Lamb